Place of CDK 4/6 and PARP inhibitors in the modern treatment approach of HER2-negative breast cancer - PDF (Russian)

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies